Connection

Federica del Monte to Heart Failure

Back to Details
This is a "connection" page, showing publications Federica del Monte has written about Heart Failure.
Federica del Monte
Connection Strength
1.642
Heart Failure
  1. Protein post-translational modifications and misfolding: new concepts in heart failure. Proteomics Clin Appl. 2014 Aug; 8(7-8):534-42.
    View in: PubMed
    Score: 0.246
  2. Intracellular devastation in heart failure. Heart Fail Rev. 2008 Jun; 13(2):151-62.
    View in: PubMed
    Score: 0.161
  3. Defects in calcium control. J Card Fail. 2002 Dec; 8(6 Suppl):S421-31.
    View in: PubMed
    Score: 0.110
  4. Targeting phospholamban by gene transfer in human heart failure. Circulation. 2002 Feb 26; 105(8):904-7.
    View in: PubMed
    Score: 0.104
  5. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation. 2001 Sep 18; 104(12):1424-9.
    View in: PubMed
    Score: 0.101
  6. Is heart failure with preserved ejection fraction a 'dementia' of the heart? Heart Fail Rev. 2022 03; 27(2):587-594.
    View in: PubMed
    Score: 0.098
  7. Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. Cardiovasc Res. 1995 Aug; 30(2):281-90.
    View in: PubMed
    Score: 0.066
  8. Response to letter regarding article "Inositol 1,4,5-trisphosphate receptors and human left ventricular myocytes". Circulation. 2014 May 27; 129(21):e510-1.
    View in: PubMed
    Score: 0.061
  9. Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. Circulation. 2013 Sep 17; 128(12):1286-97.
    View in: PubMed
    Score: 0.058
  10. Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation. 2012 Oct 30; 126(18):2208-19.
    View in: PubMed
    Score: 0.054
  11. Cardiomyogenesis in the aging and failing human heart. Circulation. 2012 Oct 09; 126(15):1869-81.
    View in: PubMed
    Score: 0.054
  12. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res. 2010 May 14; 106(9):1541-8.
    View in: PubMed
    Score: 0.046
  13. Compartmentalized expression of three novel sarco/endoplasmic reticulum Ca2+ATPase 3 isoforms including the switch to ER stress, SERCA3f, in non-failing and failing human heart. Cell Calcium. 2009 Feb; 45(2):144-54.
    View in: PubMed
    Score: 0.041
  14. Fingerprint profile of alcohol-associated heart failure in human hearts. Alcohol Clin Exp Res. 2008 May; 32(5):814-21.
    View in: PubMed
    Score: 0.040
  15. SERCA2a in heart failure: role and therapeutic prospects. J Bioenerg Biomembr. 2005 Dec; 37(6):375-80.
    View in: PubMed
    Score: 0.034
  16. Transgenic models of heart failure: elucidation of the molecular mechanisms of heart disease. Heart Fail Clin. 2005 Jul; 1(2):219-36.
    View in: PubMed
    Score: 0.033
  17. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ Res. 2005 Apr 15; 96(7):756-66.
    View in: PubMed
    Score: 0.032
  18. Antisense strategies for treatment of heart failure. Methods Mol Med. 2005; 106:69-82.
    View in: PubMed
    Score: 0.032
  19. Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications. Expert Rev Cardiovasc Ther. 2005 Jan; 3(1):85-97.
    View in: PubMed
    Score: 0.032
  20. Gene transfer in cardiac myocytes. Surg Clin North Am. 2004 Feb; 84(1):141-59, ix-x.
    View in: PubMed
    Score: 0.030
  21. Gene therapy for the treatment of heart failure--calcium signaling. Semin Thorac Cardiovasc Surg. 2003 Jul; 15(3):268-76.
    View in: PubMed
    Score: 0.029
  22. Modulating signaling pathways in hypertrophy and heart failure by gene transfer. J Card Fail. 2002 Dec; 8(6 Suppl):S389-400.
    View in: PubMed
    Score: 0.027
  23. Dissociation of hypertrophic growth from changes in myocyte contractile function. J Card Fail. 2002 Dec; 8(6 Suppl):S415-20.
    View in: PubMed
    Score: 0.027
  24. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol. 2002 Jun; 22(12):4124-35.
    View in: PubMed
    Score: 0.026
  25. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A. 2000 Jan 18; 97(2):793-8.
    View in: PubMed
    Score: 0.022
  26. From overload to failure: what happens inside the myocyte. Ann Med. 1998 Aug; 30 Suppl 1:14-23.
    View in: PubMed
    Score: 0.020
  27. Acceleration of contraction by beta-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts. Basic Res Cardiol. 1996; 91 Suppl 2:53-6.
    View in: PubMed
    Score: 0.017
  28. Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle. Eur J Pharmacol. 1992 Nov 13; 223(1):39-48.
    View in: PubMed
    Score: 0.014
  29. Isolated ventricular myocytes from failing and non-failing human heart; the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol. 1992 May; 24(5):549-64.
    View in: PubMed
    Score: 0.013
  30. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res. 2004 Oct 01; 95(7):708-16.
    View in: PubMed
    Score: 0.008
  31. Titin isoform switch in ischemic human heart disease. Circulation. 2002 Sep 10; 106(11):1333-41.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.